Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Savio

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Bollettino Chimico Farmaceutico|December 22, 1998
Lipidic matrix of albendazole: an alternative for systemic infectionsE Savio, L Domínguez, A Malanga, et al.
World Journal of Nuclear Medicine|February 2, 2013
(99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed sidePartha S Choudhury, E Savio, K K Solanki, et al.
Nuclear Medicine and Biology|June 13, 2025
Preclinical evaluation of [<sup>225</sup>Ac]Ac-PSMA-617 and in vivo effect comparison in combination with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancerE Savio, L Reyes, J Giglio, et al.
Leukemia & Lymphoma|August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphomaG Pinotti, E Zucca, E Roggero, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Bollettino Chimico Farmaceutico|December 22, 1998
Lipidic matrix of albendazole: an alternative for systemic infectionsE Savio, L Domínguez, A Malanga, et al.
World Journal of Nuclear Medicine|February 2, 2013
(99m)Tc glucarate as a potential radiopharmaceutical agent for assessment of tumor viability: from bench to the bed sidePartha S Choudhury, E Savio, K K Solanki, et al.
Nuclear Medicine and Biology|June 13, 2025
Preclinical evaluation of [<sup>225</sup>Ac]Ac-PSMA-617 and in vivo effect comparison in combination with [<sup>177</sup>Lu]Lu-PSMA-617 for prostate cancerE Savio, L Reyes, J Giglio, et al.
Leukemia & Lymphoma|August 1, 1997
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphomaG Pinotti, E Zucca, E Roggero, et al.
Pageof 2